查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2085205

生物樣本庫市場：按類型、組成、樣本類型、應用和最終用戶分類－全球預測，2026-2032年

Biobanks Market by Type, Component, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物樣本庫市場將成長至 1,752.9 億美元，複合年成長率為 11.45%。

主要市場統計數據
基準年 2025 820.2億美元
預計年份：2026年 897.2億美元
預測年份 2032 1752.9億美元
複合年成長率 (%) 11.45%

介紹

生物樣本庫已成為精準醫療、藥物研發、人群健康研究和轉化診斷的重要基礎設施。透過收集、處理、儲存和管理人類生物檢體以及相關的臨床、基因組、影像、生活方式和縱向數據，現代生物樣本庫幫助研究人員揭示疾病機制、檢驗生物標記，並開發更貼近臨床實踐的標靶治療。

生物樣本庫產業的變革性變化

生物樣本庫的格局正從檢體為中心的儲存模式轉變為資料豐富、可互通的研究平台。各機構正優先考慮標準化的預分析工作流程、自動化的檢體處理、低溫運輸完整性、數位化知情同意以及統一的元資料，以提高多中心研究中檢體的品質和可重複性。

人工智慧對生物樣本庫的累積影響

人工智慧 (AI) 透過改進檢體註釋、隊列發現、品管和預測分析，提升了生物樣本庫的價值。 AI 工具能夠幫助研究人員更快地識別相關檢體，並透過搜尋結構化和非結構化臨床數據、基因組變異、病理影像和縱向研究結果，縮短建立高品質研究隊列所需的時間。

按地區分類的關鍵見解

北美憑藉其在生物醫學研究領域的巨額投資、成熟的大學附屬醫療中心、大規模的醫療保健系統以及國家級精準醫療項目，繼續保持著生物銀行領先地區的地位。美國受益於美國國立衛生研究院（NIH）支持的基礎設施、疾病特異性樣本庫以及大規模的縱向研究計畫。同時，加拿大的公共衛生和基因組學研究舉措為人群層面的研究、對原住民數據管治的考量以及強力的倫理監管奠定了基礎。

關鍵群體特定見解

在東協地區，新加坡、泰國、馬來西亞、印尼和越南等國的生物銀行建設與不斷擴大的生物醫學研究能力、感染疾病監測、癌症研究和基因組學計畫密切相關。作為醫療保健現代化進程的一部分，海灣合作理事會（GCC）成員國正加大對精準醫療和人群健康的投入，透過國家層面的舉措學計劃、與大學附屬醫院的合作以及健康數據戰略，為生物樣本庫的建設提供支持。

主要國家的概況

美國憑藉其由美國國立衛生研究院 (NIH) 資助的大規模生物樣本庫、癌症和罕見疾病樣本庫、大學附屬醫療中心以及「我們所有人」研究計劃，在國際合作中發揮著主導作用。加拿大強調在人口健康、倫理和基因組學領域的合作，而墨西哥和巴西則正在加強其在癌症、感染疾病和人口多樣性方面的研究。在歐洲，英國生物銀行是全球典範，但德國、法國、義大利和西班牙也擁有強大的臨床研究網路、人群隊列和疾病特異性樣本庫。俄羅斯擁有強大的科學研究能力，但在國際合作中面臨更複雜的挑戰。

為行業領導者提供的實用建議

產業領導者應優先考慮生物檢體品質、標準化操作規程和可互通的元資料，因為檢體完整性直接影響下游研究的可靠性。投資於實驗室自動化、溫度監控、儲存歷史管理系統、檢驗的儲存方案以及國際認可的品管實踐，可以降低變異性，並增強學術界、臨床和製藥合作夥伴之間的信任。

調查方法

本執行摘要基於二手研究，參考了公開的生物醫學研究項目、政府衛生機構、同行評審文獻、國家基因組舉措、法律規範以及已記錄的生物樣本庫基礎設施模型。評估重點關注可驗證的指標，包括已建立的隊列、國家精準醫療計劃、公認的資料管治要求、倫理指南以及檢驗的區域醫療保健投資模式。

結論

生物樣本庫正逐漸成為精準醫療、數據驅動藥物研發和人群健康情報的戰略驅動力。其價值越來越取決於能否將高品質的生物檢體與檢驗的臨床數據、先進的分析技術、符合倫理的管治以及可擴展的合作模式結合。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生物樣本庫市場：依類型分類

  • 疾病特異性生物樣本庫
  • 基於基因組的生物樣本庫
  • 基於人群的生物樣本庫
  • 虛擬生物樣本庫

第8章：生物樣本庫市場：依組成部分分類

  • 消耗品
  • 裝置
    • 培養箱和離心機
    • 監控系統
    • 溫度控制系統
      • 低溫儲存系統
      • 冷凍庫和冷藏庫
      • 解凍裝置
  • 服務
    • 資料管理
    • 樣品分析
    • 保存和加工
    • 運輸

第9章：生物樣本庫市場：依樣本類型分類

  • 血液製品
  • 細胞株
  • 核酸
  • 組織

第10章：生物樣本庫市場：依應用領域分類

  • 臨床診斷
  • 個人化醫療
  • 研究
  • 治療
    • 藥物研發
    • 基因編輯

第11章：生物樣本庫市場：依最終使用者分類

  • 學術機構
  • 合約研究和製造組織
  • 醫院
  • 製藥和生物技術公司

第12章：生物樣本庫市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：生物樣本庫市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：生物樣本庫市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Acorn Biolabs Inc.
  • Anuva
  • ASKION GmbH
  • Avantor, Inc.
  • Azenta Life Science
  • Bay Biosciences LLC
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson and Company
  • BioIVT, LLC
  • BioKryo by L'AIR LIQUIDE SA
  • BioLife Solutions Inc.
  • BocaBio
  • Bruker Corporation
  • CELLIVIA 3 SA
  • Celltex Therapeutics Corporation
  • Charles River Laboratories International, Inc.
  • Cryoport Systems, LLC
  • CTIBiotech by Swedish Orphan Biovitrum AB
  • Cureline, Inc
  • Firalis Group
  • Greiner Bio-One International GmbH
  • Hamilton Company
  • Hope Biosciences, LLC
  • Lonza Group Ltd.
  • LVL technologies GmbH & Co. KG.
  • Merck KGaA
  • Precision Cellular Storage Ltd.
  • ProteoGenex, Inc.
  • Provia Laboratories, Inc.
  • Qiagen NV
  • Standard BioTools Inc.
  • STEMCELL Technologies
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited
Product Code: MRR-437D4595886E

The Biobanks Market is projected to grow by USD 175.29 billion at a CAGR of 11.45% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 82.02 billion
Estimated Year [2026] USD 89.72 billion
Forecast Year [2032] USD 175.29 billion
CAGR (%) 11.45%

Introduction

Biobanks have become critical infrastructure for precision medicine, drug discovery, population health research, and translational diagnostics. By collecting, processing, storing, and governing human biospecimens alongside linked clinical, genomic, imaging, lifestyle, and longitudinal data, modern biobanks help researchers identify disease mechanisms, validate biomarkers, and develop targeted therapies with stronger real-world relevance.

Demand is being shaped by the expansion of genomics, oncology research, rare disease programs, immunology, regenerative medicine, and public health surveillance. Large-scale initiatives such as UK Biobank, with approximately 500,000 participants, and the U.S. All of Us Research Program, designed to enroll one million or more participants, demonstrate how population-scale biospecimen and data resources are becoming foundational to evidence-based healthcare innovation.

Transformative Shifts in the Biobanks Landscape

The biobanks landscape is shifting from specimen-centered repositories to data-rich, interoperable research platforms. Organizations are prioritizing standardized pre-analytical workflows, automated sample handling, cold-chain integrity, digital consent, and harmonized metadata to improve sample quality and reproducibility across multi-site studies.

A second major shift is the rise of participant-centric and disease-specific biobanking. Patients are increasingly engaged through dynamic consent models, return-of-results discussions, and governance frameworks that emphasize privacy, transparency, and equitable access. This is especially important as biobanks support multi-omics research, real-world evidence generation, and clinical trial matching for precision oncology, cardiometabolic disease, neurodegeneration, and infectious disease studies.

Cumulative Impact of Artificial Intelligence on Biobanks

Artificial intelligence is accelerating the value of biobanks by improving sample annotation, cohort discovery, quality control, and predictive analytics. AI-enabled tools can help researchers identify suitable specimens faster by searching structured and unstructured clinical data, genomic variants, pathology images, and longitudinal outcomes, reducing the time required to build high-quality research cohorts.

The cumulative impact is strongest when AI is paired with robust governance and interoperable data standards. Machine learning can support biomarker discovery, disease-risk modeling, and clinical trial feasibility, but its performance depends on representative datasets, clear provenance, bias monitoring, and privacy-preserving methods such as federated learning. As a result, leading biobanks are investing in data curation, secure analytics environments, and FAIR data principles to ensure AI outputs remain auditable and clinically credible.

Key Regional Insights

North America remains a leading biobanking region due to deep investment in biomedical research, mature academic medical centers, large health systems, and national precision medicine programs. The United States benefits from NIH-supported infrastructure, disease-focused repositories, and large longitudinal programs, while Canada's public health and genomics initiatives support population-level research, Indigenous data governance considerations, and strong ethical oversight.

Europe is distinguished by coordinated research networks, GDPR-driven data protection, and cross-border initiatives that encourage harmonized standards across clinical research and population health. Asia-Pacific is expanding as China, Japan, India, South Korea, Singapore, and Australia build genomic medicine capabilities, national biobank assets, and hospital-linked biospecimen networks. Latin America, the Middle East, and Africa are gaining strategic importance because their diverse populations can improve global disease understanding, although investment in cold-chain infrastructure, consent harmonization, workforce training, and sustainable research funding remains uneven across markets.

Key Group Insights

Within ASEAN, biobanking development is linked to expanding biomedical research capacity, infectious disease surveillance, cancer research, and genomics programs in countries such as Singapore, Thailand, Malaysia, Indonesia, and Vietnam. The GCC is investing in precision medicine and population health as part of broader healthcare modernization, with national genome initiatives, academic medical partnerships, and health data strategies supporting biobank development.

The European Union provides one of the most structured environments for cross-border biobank collaboration through data protection rules, research funding frameworks, and infrastructure networks that promote interoperability and ethical access. BRICS countries are important because they combine large populations, genetic diversity, and rising biotechnology investment, although regulatory maturity and data-sharing practices vary. G7 countries continue to set benchmarks in data governance, translational research, and pharmaceutical partnerships, while NATO countries increasingly recognize biobanking relevance for biodefense, public health resilience, and pandemic preparedness.

Key Country Insights

The United States leads through extensive NIH-funded repositories, cancer and rare disease collections, academic medical centers, and the All of Us Research Program. Canada emphasizes population health, ethics, and genomics collaboration, while Mexico and Brazil are strengthening cancer, infectious disease, and population diversity research. In Europe, the United Kingdom's UK Biobank is a global reference model, while Germany, France, Italy, and Spain maintain strong clinical research networks, population cohorts, and disease-specific repositories; Russia has scientific capacity but faces more complex international collaboration dynamics.

China is scaling biobanking through major hospitals, genomics research, and national precision medicine priorities, while India's large and diverse population creates significant opportunity for population genomics, newborn screening research, and disease-specific repositories. Japan and South Korea are advanced in precision medicine, aging research, oncology, and high-quality clinical data integration. Australia combines population health expertise, longitudinal cohorts, Indigenous health governance considerations, and strong research ethics frameworks, supporting its role as a major Asia-Pacific biobanking hub.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize biospecimen quality, standardized operating procedures, and interoperable metadata because sample integrity directly affects downstream research reliability. Investments in laboratory automation, temperature monitoring, chain-of-custody systems, validated storage protocols, and internationally recognized quality management practices can reduce variability and improve trust among academic, clinical, and pharmaceutical partners.

Executives should also strengthen data governance by adopting dynamic consent, privacy-by-design architecture, controlled access committees, and transparent benefit-sharing practices. To compete in AI-enabled biobanking, organizations should build secure analytics environments, curate high-quality linked datasets, align with FAIR principles, and develop partnerships with hospitals, contract research organizations, diagnostics developers, and biopharmaceutical companies.

Research Methodology

This executive summary is based on secondary research from publicly available biomedical research programs, government health agencies, peer-reviewed literature, national genomics initiatives, regulatory frameworks, and documented biobank infrastructure models. The assessment emphasizes verifiable indicators such as established population cohorts, national precision medicine programs, recognized data governance requirements, ethical guidelines, and documented regional healthcare investment patterns.

The methodology applies qualitative triangulation across scientific, regulatory, operational, and commercial sources to identify consistent trends in biobanking demand, technology adoption, AI integration, and geographic expansion. Insights are structured to support strategic planning for biobank operators, pharmaceutical companies, academic research centers, healthcare systems, diagnostics firms, and investors evaluating the global biobanks landscape without relying on market sizing, market share, or forecasting assumptions.

Conclusion

Biobanks are evolving into strategic engines for precision medicine, data-driven drug development, and population health intelligence. Their value increasingly depends on the ability to combine high-quality biospecimens with validated clinical data, advanced analytics, ethical governance, and scalable collaboration models.

Organizations that invest in automation, AI-ready data infrastructure, global standards, and participant trust will be best positioned to capture long-term opportunities. As genomics, multi-omics, and real-world evidence become central to healthcare innovation, biobanks will remain indispensable to the future of biomedical discovery and personalized care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Biobanks Market, by Type

  • 7.1. Disease-Oriented Biobanks
  • 7.2. Genomic-Based Biobanks
  • 7.3. Population-Based Biobanks
  • 7.4. Virtual Biobanks

8. Biobanks Market, by Component

  • 8.1. Consumables
  • 8.2. Equipment
    • 8.2.1. Incubators & Centrifuges
    • 8.2.2. Monitoring Systems
    • 8.2.3. Temperature Control Systems
      • 8.2.3.1. Cryogenic Storage Systems
      • 8.2.3.2. Freezers & Refrigerators
      • 8.2.3.3. Thawing Equipment
  • 8.3. Services
    • 8.3.1. Data Management
    • 8.3.2. Sample Analysis
    • 8.3.3. Storage & Processing
    • 8.3.4. Transport

9. Biobanks Market, by Sample Type

  • 9.1. Blood Derivatives
  • 9.2. Cell Lines
  • 9.3. Nucleic Acid
  • 9.4. Tissues

10. Biobanks Market, by Application

  • 10.1. Clinical Diagnostics
  • 10.2. Personalized Medicine
  • 10.3. Research
  • 10.4. Therapeutics
    • 10.4.1. Drug Development
    • 10.4.2. Gene Editing

11. Biobanks Market, by End User

  • 11.1. Academic Institutions
  • 11.2. Contract Research & Manufacturing Organizations
  • 11.3. Hospitals
  • 11.4. Pharmaceutical & Biotech Companies

12. Biobanks Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Biobanks Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biobanks Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Acorn Biolabs Inc.
  • 16.2. Anuva
  • 16.3. ASKION GmbH
  • 16.4. Avantor, Inc.
  • 16.5. Azenta Life Science
  • 16.6. Bay Biosciences LLC
  • 16.7. Beckman Coulter, Inc. by Danaher Corporation
  • 16.8. Becton, Dickinson and Company
  • 16.9. BioIVT, LLC
  • 16.10. BioKryo by L'AIR LIQUIDE S.A.
  • 16.11. BioLife Solutions Inc.
  • 16.12. BocaBio
  • 16.13. Bruker Corporation
  • 16.14. CELLIVIA 3 S.A.
  • 16.15. Celltex Therapeutics Corporation
  • 16.16. Charles River Laboratories International, Inc.
  • 16.17. Cryoport Systems, LLC
  • 16.18. CTIBiotech by Swedish Orphan Biovitrum AB
  • 16.19. Cureline, Inc
  • 16.20. Firalis Group
  • 16.21. Greiner Bio-One International GmbH
  • 16.22. Hamilton Company
  • 16.23. Hope Biosciences, LLC
  • 16.24. Lonza Group Ltd.
  • 16.25. LVL technologies GmbH & Co. KG.
  • 16.26. Merck KGaA
  • 16.27. Precision Cellular Storage Ltd.
  • 16.28. ProteoGenex, Inc.
  • 16.29. Provia Laboratories, Inc.
  • 16.30. Qiagen N.V.
  • 16.31. Standard BioTools Inc.
  • 16.32. STEMCELL Technologies
  • 16.33. Tecan Trading AG
  • 16.34. Thermo Fisher Scientific Inc.
  • 16.35. UK Biobank Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOBANKS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIOBANKS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIOBANKS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIOBANKS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOBANKS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIOBANKS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIOBANKS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIOBANKS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DISEASE-ORIENTED BIOBANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DISEASE-ORIENTED BIOBANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DISEASE-ORIENTED BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GENOMIC-BASED BIOBANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GENOMIC-BASED BIOBANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GENOMIC-BASED BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL POPULATION-BASED BIOBANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL POPULATION-BASED BIOBANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL POPULATION-BASED BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VIRTUAL BIOBANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VIRTUAL BIOBANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VIRTUAL BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INCUBATORS & CENTRIFUGES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INCUBATORS & CENTRIFUGES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INCUBATORS & CENTRIFUGES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TEMPERATURE CONTROL SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TEMPERATURE CONTROL SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TEMPERATURE CONTROL SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CRYOGENIC STORAGE SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CRYOGENIC STORAGE SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CRYOGENIC STORAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FREEZERS & REFRIGERATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FREEZERS & REFRIGERATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FREEZERS & REFRIGERATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL THAWING EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL THAWING EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DATA MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DATA MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DATA MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SAMPLE ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SAMPLE ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SAMPLE ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STORAGE & PROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STORAGE & PROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STORAGE & PROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TRANSPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRANSPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD DERIVATIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD DERIVATIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELL LINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CELL LINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CELL LINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NUCLEIC ACID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NUCLEIC ACID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NUCLEIC ACID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TISSUES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TISSUES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TISSUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL THERAPEUTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL THERAPEUTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GENE EDITING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOBANKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. GCC BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. GCC BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. GCC BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 175. GCC BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 176. GCC BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 177. GCC BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. GCC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. GCC BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 181. GCC BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. G7 BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 205. G7 BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 206. G7 BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. G7 BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. G7 BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. G7 BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. G7 BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 211. G7 BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NATO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 215. NATO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 216. NATO BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 217. NATO BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 218. NATO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. NATO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. NATO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 221. NATO BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 233. CANADA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 234. CANADA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 236. CANADA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 237. CANADA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 238. CANADA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 239. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. CANADA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 242. CANADA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. MEXICO BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 244. MEXICO BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 246. MEXICO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 247. MEXICO BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 248. MEXICO BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 249. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. MEXICO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 252. MEXICO BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. BRAZIL BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. BRAZIL BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 256. BRAZIL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 257. BRAZIL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 258. BRAZIL BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 259. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. BRAZIL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 262. BRAZIL BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED KINGDOM BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED KINGDOM BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED KINGDOM BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED KINGDOM BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. GERMANY BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 276. GERMANY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 282. GERMANY BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. FRANCE BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 284. FRANCE BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 286. FRANCE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 287. FRANCE BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 288. FRANCE BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 289. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. FRANCE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 292. FRANCE BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. RUSSIA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. RUSSIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 296. RUSSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 297. RUSSIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 298. RUSSIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 299. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. RUSSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 302. RUSSIA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 303. ITALY BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 304. ITALY BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 306. ITALY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 307. ITALY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 308. ITALY BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 309. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. ITALY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 312. ITALY BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. SPAIN BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. SPAIN BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 316. SPAIN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 317. SPAIN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 318. SPAIN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 319. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 321. SPAIN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 322. SPAIN BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 333. INDIA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. INDIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. INDIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 336. INDIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 337. INDIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 338. INDIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 339. INDIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 340. INDIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 341. INDIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 342. INDIA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. JAPAN BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 344. JAPAN BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. JAPAN BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 346. JAPAN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 347. JAPAN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 348. JAPAN BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 349. JAPAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 350. JAPAN BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 351. JAPAN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 352. JAPAN BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 353. AUSTRALIA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. AUSTRALIA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. AUSTRALIA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 356. AUSTRALIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 357. AUSTRALIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 358. AUSTRALIA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 359. AUSTRALIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 360. AUSTRALIA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 361. AUSTRALIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 362. AUSTRALIA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 363. SOUTH KOREA BIOBANKS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 364. SOUTH KOREA BIOBANKS MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. SOUTH KOREA BIOBANKS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 366. SOUTH KOREA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 367. SOUTH KOREA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 368. SOUTH KOREA BIOBANKS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 369. SOUTH KOREA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 370. SOUTH KOREA BIOBANKS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 371. SOUTH KOREA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2018-2032 (USD MILLION)
  • TABLE 372. SOUTH KOREA BIOBANKS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)